Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer
- PMID: 9169405
- DOI: 10.1074/jbc.272.23.14501
Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer
Abstract
Mutations in Ras family members that confer oncogenic potential are frequently observed in specific human cancers. We report that human non-small cell lung cancer (NSCLC) lines that harbor oncogenic mutations in Ki-Ras (H460, A549, H2122) synthesized high levels of prostaglandin E2 (PGE2) compared with NSCLC lacking Ras mutations or non-transformed lung epithelial cells (BEAS-2B). This increased PGE2 production was mediated by constitutively high expression of 85-kDa cytosolic phospholipase A2 (cPLA2) and cyclooxygenase 2 (COX-2). The increased expression of cPLA2 protein was mediated through elevated mRNA levels and activation of the cPLA2 promoter. Induction of cPLA2 promoter activity was blocked by expression of dominant-negative forms of Ras. Inhibition of Ras by the farnesyltransferase inhibitor BZA-5B inhibited prostaglandin synthesis in H2122 cells by decreasing expression of both cPLA2 and COX-2. Finally, inhibitors of eicosanoid synthesis blocked anchorage-independent growth of NSCLC lines exhibiting Ki-Ras mutations. These results identify cPLA2 as a novel Ras-inducible regulator of eicosanoid synthesis that participates in cellular transformation.
Similar articles
-
Lung Krüppel-like factor (LKLF) is a transcriptional activator of the cytosolic phospholipase A2 alpha promoter.Biochem J. 2005 Apr 1;387(Pt 1):239-46. doi: 10.1042/BJ20041458. Biochem J. 2005. PMID: 15540987 Free PMC article.
-
Cytosolic phospholipase A2 Group IValpha but not secreted phospholipase A2 Group IIA, V, or X induces interleukin-8 and cyclooxygenase-2 gene and protein expression through peroxisome proliferator-activated receptors gamma 1 and 2 in human lung cells.J Biol Chem. 2004 Nov 19;279(47):48550-61. doi: 10.1074/jbc.M408926200. Epub 2004 Aug 25. J Biol Chem. 2004. PMID: 15331599
-
Induction of cytosolic phospholipase A2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells.J Biol Chem. 2001 Jan 12;276(2):1226-32. doi: 10.1074/jbc.M003581200. J Biol Chem. 2001. PMID: 11042196
-
Augmented prostaglandin E2 generation resulting from increased activities of cytosolic and secretory phospholipase A2 and induction of cyclooxygenase-2 in interleukin-1 beta-stimulated rat calvarial cells during the mineralizing phase.Inflamm Res. 2000 Mar;49(3):102-11. doi: 10.1007/s000110050566. Inflamm Res. 2000. PMID: 10807497
-
Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells.Life Sci. 1997;60(1):67-78. doi: 10.1016/s0024-3205(96)00590-5. Life Sci. 1997. PMID: 8995534
Cited by
-
Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies.Cell Rep Med. 2023 Dec 19;4(12):101311. doi: 10.1016/j.xcrm.2023.101311. Epub 2023 Dec 11. Cell Rep Med. 2023. PMID: 38086380 Free PMC article.
-
Inhibition of Cytosolic Phospholipase A2α Induces Apoptosis in Multiple Myeloma Cells.Molecules. 2021 Dec 9;26(24):7447. doi: 10.3390/molecules26247447. Molecules. 2021. PMID: 34946532 Free PMC article.
-
A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.Int J Mol Sci. 2021 Aug 30;22(17):9411. doi: 10.3390/ijms22179411. Int J Mol Sci. 2021. PMID: 34502319 Free PMC article.
-
Targeting cPLA2α inhibits gastric cancer and augments chemotherapy efficacy via suppressing Ras/MEK/ERK and Akt/β-catenin pathways.Cancer Chemother Pharmacol. 2021 Oct;88(4):689-697. doi: 10.1007/s00280-021-04322-1. Epub 2021 Jul 13. Cancer Chemother Pharmacol. 2021. PMID: 34255137
-
Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer.Front Immunol. 2019 May 10;10:954. doi: 10.3389/fimmu.2019.00954. eCollection 2019. Front Immunol. 2019. PMID: 31134065 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
